Synthesis of 1,2,4-triazole derivatives containing benzothiazoles as pharmacologically active molecule

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 26, Issue 4, 2011, Pages 527-534

  Patel, Navin B ^a   Khan, Imran H ^a  

^a VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

Author keywords

1,2,4 Triazole; Antimicrobial activity; Antitubercular activity

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 2 (3 PYRIDYL) 5 (4 NITROPHENYL) 1,3,4 OXADIAZOLE; BENZOTHIAZOLE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

AGAR MEDIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS CLAVATUS; ASPERGILLUS NIGER; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; BENZOTHIAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

ASPERGILLUS CLAVATUS; ASPERGILLUS NIGER; CANDIDA ALBICANS; ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 79959871885     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2010.535794     Document Type: Article

References (28)

1. Stokstad, E. Infectious disease. Drug-resistant TB on the rise. Science 2000, 287, 2391.
2. WHO Global Tuberculosis Programme-Tuberculosis Fact Sheet, 2002. World Health Organization. Global Tuberculosis Control, WHO Report 2001, 2002.
3. World Health Organization, Geneva, Switzerland, WHO/CDS/ TB/2001, 287.
4. Mooran, N. WHO issues another gloomy tuberculosis report. Nat. Med. 1996, 2, 377.
5. Dye, C., Scheele, S., Dolin, P., Pathania, V., Raviglione, M.C. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. J. Am. Med. Assoc. 1999, 282, 677-686. (Pubitemid 29384157)
6. Dooley, S.W., Jarvis, W.R., Martone, W.J., Snider, D.E. Jr. Multidrugresistant tuberculosis. Ann. Intern. Med. 1992, 117, 257-259.
7. Raviglione, M.C., Snider, D.E. Jr, Kochi, A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995, 273, 220-226.
8. Farmer, P., Bayona, J., Becerra, M., Furin, J., Henry, C., Hiatt, H., Kim, J.Y., Mitnick, C., Nardell, E., Shin, S. The dilemma of MDR-TB in the global era. Int. J. Tuberc. Lung Dis. 1998, 2, 869-876. (Pubitemid 28539468)
9. Hudson, A., Imamura, T., Gutteridge, W., Kanyok, T., Nunn, P. The Current Anti-TB Drug Research and Development Pipeline. WHO TDR/PRD/03.1W Geneva, 2003.
10. Tripathi, R.P., Tewari, N., Dwivedi, N., Tiwari, V.K. Fighting tuberculosis: an old disease with new challenges. Med. Res. Rev. 2005, 25, 93-131. (Pubitemid 39642233)
11. Banfi, E., Scialino, G., Zampieri, D., Mamolo, M.G., Vio, L., Ferrone, M., Fermeglia, M., Paneni, M.S., Pricl, S. Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. J. Antimicrob. Chemother. 2006, 58, 76-84. (Pubitemid 44294990)
12. Ulusoy, N., Gürsoy, A., Otük, G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco 2001, 56, 947-952. (Pubitemid 34019224)
13. Muhi-Eldeen Z, Nadir M, Aljobory NR, Husseen F, Stohs SJ. Synthesis and antimicrobial evaluation of 3-(4-tert-amino-2- butynyl)thio and alkyl/alkenylthio-4,5-disubstituted-4H-1,2,4- triazoles. Eur. J. Med. Chem. 1991, 26, 237-241.
14. Küĉükgüzel, I., Tatar, E., Küĉü kgüzel, S.G., Rollas, S., De Clercq, E. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro- 3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti- HIV and anti-tuberculosis agents. Eur. J. Med. Chem. 2008, 43, 381-392. (Pubitemid 351215610)
15. Banfi, E., Mamolo, M.G., Zampieri, D., Vio, L., Monti Bragadin, C. Antimycobacterial activity of N1-[1-[3-aryl-1-(pyridin-2-, 3- or 4-yl)-3-oxo] propyl]-2-pyridinecarboxamidrazones. J. Antimicrob. Chemother. 2001, 48, 705-707.
16. Jackson, C.J., Lamb, D.C., Kelly, D.E., Kelly, S.L. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol. Lett. 2000, 192, 159-162.
17. Guardiola-Diaz, H.M., Foster, L.A., Mushrush, D., Vaz, A.D. Azoleantifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem. Pharmacol. 2001, 61, 1463-1470. (Pubitemid 32476901)
18. McLean, K.J., Marshall, K.R., Richmond, A., Hunter, I.S., Fowler, K., Kieser, T., Gurcha, S.S., Besra, G.S., Munro, A.W. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 2002, 30, 314-318.
19. Dabiri, M., Salehi, P., Baghbanzadeh, M., Bahramnejad, M. A facile procedure for the one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles. Tetrahedron Lett. 2006, 47, 6983-6986. (Pubitemid 44278974)
20. Navarrete-Vázquez, G., Molina-Salinas, G.M., Duarte- Fajardo, Z.V., Vargas-Villarreal, J., Estrada-Soto, S., González- Salazar, F., Hernández-Núñez, E., Said-Fernández, S. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol- 2-yl)pyridines. Bioorg. Med. Chem. 2007, 15, 5502-5508. (Pubitemid 46962995)
21. Podust, L.M., Poulos, T.L., Waterman, M.R. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3068-3073. (Pubitemid 32220800)
22. Bellamine, A., Mangla, A.T., Nes, W.D., Waterman, M.R. Characterization and catalytic properties of the sterol 14alphademethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 8937-8942. (Pubitemid 29374686)
23. Barnett, C.J. Exchange Amination Process for Preparing 2-Hydrazinobenzothiazoles. U.S. Patent 3,937,714.
24. Kumar, V., Roy, R.K., Kumar, V., Kukshal, A., Yadav, V.P. Synthesis and antimicrobial activity of 2-(6-substituted-1,3-benzothiazol- 2-yl)-N-(4-halophenyl)hydrazinecarbothiomide. J. Indian Chem. Soc. 2008, 85B, 333-335. (Pubitemid 351548108)
25. Rattan, A. Antimicrobials in Laboratory Medicine. New Delhi: Churchill BI Livingstone, 2000, pp. 85-108.
26. Anargyros, P., Astill, D.S., Lim, I.S. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J. Clin. Microbiol. 1990, 28, 1288-1291. (Pubitemid 20194420)
27. Shah, R.R., Mehta, R.D., Parikh, A.R. Studies on isoniazide derivatives: preparation and antimicrobial activity of 2-aryl-3- (pyridylcarbomyl)-5- carboxymethyl-4-thiazolidinones. J. Indian Chem. Soc. 1985, 62B, 255-257. (Pubitemid 17169772)
28. Desai, N.C., Shukla, H.K., Tahker, K.A. Some new 2-aryl-3- isonicotamido-4-thiazolidinones and their 5-carboxymethyl homologues as potential antitubercular and antibacterial agent. J. Indian Chem. Soc. 1984, 61B, 239-240 (Pubitemid 15181128)